News

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...
The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...
A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.
A recommended 150 minutes per week at moderate intensity can help reduce liver inflammation and rid the organ of fat.
Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...
People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic ...
Despite their benefits, there are a number of things to consider before taking weight loss drugs – including possible ...
Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...
Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...
Doctors are also seeing success in treating people with certain liver diseases. Isaacs prescribes GLP-1s for people with a ...